Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 2/20 | 1.00 |
| ▸ | HTR2A | P28223 | 2/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.58 |
| ▸ | SQLE | Q14534 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butenafine SCHEMBL29354083 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| Butenafine SCHEMBL20456391 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| Butenafine SCHEMBL29459249 | 0.99 | LMNA (0.97) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| Butenafine SCHEMBL262301 | 0.99 | LMNA (0.97) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| Butenafine SCHEMBL676912 | 0.99 | LMNA (0.97) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| Butenafine SCHEMBL1648813 | 0.97 | CYP2D6 (0.94) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| Butenafine SCHEMBL500751 | 0.92 | CYP2D6 (0.85) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| SCHEMBL9695182 | 0.89 | CYP2D6 (0.80) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| SCHEMBL9312678 | 0.87 | CYP2D6 (0.78) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A | |
| Hydrochloric Acid SCHEMBL9314916 | 0.86 | LMNA (0.76) | CYP2D6LMNASLC6A2SIGMAR1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11224 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260102419-A1 | USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4719384-A2 | COMPOUNDS WITH ANTIFUNGAL PROPERTIES | Trustees of Dartmouth College (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260076924-A1 | COMPOSITIONS AND METHODS OF TREATMENT FOR TINEA PEDIS | THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4676500-A2 | MICROBIAL CONSORTIA | Kanvas Biosciences, Inc (US) | 2026-01-14 | — | — | EP | claimed |
| US-20260007753-A1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2026-01-08 | — | — | US | claimed |
| WO-2025264604-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | claimed |
| US-12419959-B2 | Dermal skin protectant and carrier | Inspired Material Strategies, LLC (US) | 2025-09-23 | — | — | US | claimed |
| EP-1024814-A2 | USE OF ANTIFUNGAL AGENTS FOR THE TOPICAL TREATMENT OF FUNGUS-INDUCED MUCOSITIS | Ponikau, Jens (US) | 2000-08-09 | — | — | EP | claimed |
| WO-1999053913-A1 | TOPICAL FORMULATIONS FOR THE TREATMENT OF NAIL FUNGAL DISEASES | BERTEK PHARMACEUTICALS, INC. (US) | 1999-10-28 | — | — | WO | claimed |
| WO-1999049895-A2 | METHOD FOR INCREASING THE PERMEABILITY OF HORNY HUMAN TISSUE | JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) | 1999-10-07 | — | — | WO | claimed |
| WO-1999049835-A1 | AN ACIDIFIED COMPOSITION FOR TOPICAL TREATMENT OF NAIL AND SKIN CONDITIONS | JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) | 1999-10-07 | — | — | WO | claimed |
| WO-1999020261-A2 | USE OF ANTIGUNAL AGENTS FOR THE TOPIAL TREATMENT OF FUNGUS-INDUCED MUCOSITIS | PONIKAU JENS (US) | 1999-04-29 | — | — | WO | claimed |
| WO-1997006676-A1 | MICROBICIDAL FORMULATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-02-27 | — | — | WO | claimed |
| US-5120735-A | Synergistic mixture of miconazole, ketoconazole or fluconazole and N-4-tertbutylbenzyl-N-methyl-1-naphthalenemethylamine | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1992-06-09 | — | — | US | claimed |
| EP-0440298-A1 | Topical preparations for treating human nails | BROCADES PHARMA B.V. (NL) | 1991-08-07 | — | — | EP | claimed |
| EP-0310122-B1 | ANTIFUNGAL COMPOSITION | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1991-07-24 | — | — | EP | claimed |
| EP-0310122-A1 | Antifungal composition | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1989-04-05 | — | — | EP | claimed |